Last reviewed · How we verify

Placebo matching Tamsulosine Arrow LP — Competitive Intelligence Brief

Placebo matching Tamsulosine Arrow LP (Placebo matching Tamsulosine Arrow LP) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Placebo (matching formulation). Area: Urology.

marketed Placebo (matching formulation) Urology Small molecule Live · refreshed every 30 min

Target snapshot

Placebo matching Tamsulosine Arrow LP (Placebo matching Tamsulosine Arrow LP) — Pierre Fabre Medicament. This is a placebo formulation designed to match the appearance and administration profile of Tamsulosin Arrow LP, a selective alpha-1A adrenergic receptor antagonist used in benign prostatic hyperplasia treatment.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Placebo matching Tamsulosine Arrow LP TARGET Placebo matching Tamsulosine Arrow LP Pierre Fabre Medicament marketed Placebo (matching formulation)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Placebo (matching formulation) class)

  1. Pierre Fabre Medicament · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo matching Tamsulosine Arrow LP — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matching-tamsulosine-arrow-lp. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: